WS
BIO icon

Wedbush Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wedbush Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-851
Closed -$232K – 1115
2024
Q2 		$232K Sell
851
-889
-51% -$259K 0.01% 994
2024
Q1 		$602K Sell
1,740
-71
-4% -$23.3K 0.02% 569
2023
Q4 		$585K Sell
1,811
-34
-2% -$10.7K 0.03% 501
2023
Q3 		$661K Sell
1,845
-3
-0.2% -$1.16K 0.03% 434
2023
Q2 		$701K Sell
1,848
-8
-0.4% -$3.26K 0.03% 433
2023
Q1 		$889K Buy
1,856
+1
+0.1% +$468 0.04% 352
2022
Q4 		$780K Buy
1,855
+3
+0.2% +$1.21K 0.04% 373
2022
Q3 		$773K Buy
1,852
+51
+3% +$25.4K 0.04% 353
2022
Q2 		$891K Hold
1,801
– – 0.05% 323
2022
Q1 		$1.01M Sell
1,801
-6
-0.3% -$3.62K 0.05% 338
2021
Q4 		$1.36M Sell
1,807
-3
-0.2% -$2.25K 0.06% 280
2021
Q3 		$1.35M Hold
1,810
– – 0.06% 281
2021
Q2 		$1.17M Hold
1,810
– – 0.06% 324
2021
Q1 		$1.03M Buy
+1,810
New +$1.07M 0.06% 323
2016
Q1 		– Sell
-21,472
Closed -$2.98M – 758
2015
Q4 		$2.98M Hold
21,472
– – 0.54% 30
2015
Q3 		$2.88M Sell
21,472
-2,000
-9% -$288K 0.58% 22
2015
Q2 		$3.54M Sell
23,472
-1,400
-6% -$200K 0.65% 21
2015
Q1 		$3.36M Hold
24,872
– – 0.57% 24
2014
Q4 		$3M Hold
24,872
– – 0.46% 33
2014
Q3 		$2.82M Hold
24,872
– – 0.44% 34
2014
Q2 		$2.98M Hold
24,872
– – 0.47% 37
2014
Q1 		$3.19M Hold
24,872
– – 0.56% 27
2013
Q4 		$3.07M Hold
24,872
– – 0.73% 22
2013
Q3 		$2.92M Hold
24,872
– – 0.77% 17
2013
Q2 		$2.79M Buy
+24,872
New +$2.92M 0.77% 19

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wedbush Securities's BIO Position: Q3 2024 in Review

Wedbush Securities sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 851 shares — an estimated $232K sold.

Wedbush Securities first reported a position in BIO in Q2 2013 and held it in 25 quarters. The position peaked at $3.54M in Q2 2015. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Wedbush Securities reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Wedbush Securities sold 851 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $232K.
  • Wedbush Securities first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 25 quarters.
  • Wedbush Securities's Bio-Rad Laboratories Class A position peaked at $3.54M in Q2 2015.
  • 438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Wedbush Securities's 13F filing for Q3 2024, filed 8 Nov 2024.